-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $11

Benzinga·01/16/2026 15:58:40
Listen to the news
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9 to $11.